Fred Hutchinson Cancer Research Center


Research facility

Location:
Seattle, Canada


Publications in cooperation with FAU scientists


Go to first page Go to previous page 1 of 2 Go to next page Go to last page
Huang, M., Qi, C.Z., Ramsey, S., Briggs, A., Zhao, J., Haiderali, A.,... Fasching, P. (2019). Evaluation of pathological complete response as a trial-level surrogate for long-term survival outcomes among triple-negative breast cancer patients receiving neoadjuvant therapy. In ANNALS OF ONCOLOGY (pp. 34-+). Berlin, DE: OXFORD: OXFORD UNIV PRESS.
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-18-2726
Machiela, M.J., Gruenewald, T.G.P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E.,... Delattre, O. (2018). Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. In CANCER RESEARCH. Atlanta, GA, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Machiela, M.J., Grunewald, T.G.P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E.,... Delattre, O. (2018). Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05537-2
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05427-7
Machiela, M.J., Gruenewald, T.G., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E.,... Delattre, O. (2018). Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Kelemen, L.E., Earp, M., Fridley, B.L., Chenevix-Trench, G., Fasching, P., Beckmann, M.,... Berchuck, A. (2018). rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences, 19(9). https://dx.doi.org/10.3390/ijms19092473
Earp, M., Tyrer, J.P., Winham, S.J., Lin, H.-Y., Chornokur, G., Dennis, J.,... Phelan, C.M. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS ONE, 13(7). https://dx.doi.org/10.1371/journal.pone.0197561
Kar, S.P., Adler, E., Tyrer, J., Hazelett, D., Anton-Culver, H., Bandera, E.V.,... Lawrenson, K. (2017). Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer, 116(4), 524-535. https://dx.doi.org/10.1038/bjc.2016.426
Minlikeeva, A.N., Freudenheim, J.L., Eng, K.H., Cannioto, R.A., Friel, G., Szender, J.B.,... Moysich, K.B. (2017). History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology Biomarkers & Prevention, 26(9), 1470-1473. https://dx.doi.org/10.1158/1055-9965.EPI-17-0367
Sucheston-Campbell, L.E., Cannioto, R., Clay, A.I., Etter, J.L., Eng, K.H., Liu, S.,... Moysich, K.B. (2017). No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival. Cancer Epidemiology Biomarkers & Prevention, 26(3), 420-424. https://dx.doi.org/10.1158/1055-9965.EPI-16-0631
Dixon, S.C., Nagle, C.M., Thrift, A.P., Pharoah, P.D.P., Pearce, C.L., Zheng, W.,... Webb, P.M. (2016). Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology, 45(3), 884-95. https://dx.doi.org/10.1093/ije/dyw158
Hampras, S.S., Sucheston-Campbell, L.E., Cannioto, R., Chang-Claude, J., Modugno, F., Doerk, T.,... Moysich, K.B. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. https://dx.doi.org/10.18632/oncotarget.10215
Zhao, Z., Wen, W., Michailidou, K., Bolla, M.K., Wang, Q., Zhang, B.,... Zheng, W. (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control, 27(5), 679-93. https://dx.doi.org/10.1007/s10552-016-0741-6
Guo, Y., Andersen, S.W., Shu, X.-O., Michailidou, K., Bolla, M.K., Wang, Q.,... Zheng, W. (2016). Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. Plos Medicine, 13(8). https://dx.doi.org/10.1371/journal.pmed.1002105
Permuth, J.B., Reid, B., Earp, M., Chen, Y.A., Monteiro, A.N.A., Chen, Z.,... Sellers, T.A. (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget, 7(45), 72381-72394. https://dx.doi.org/10.18632/oncotarget.10546
Anderson, S., Poudel, K.R., Roh-Johnson, M., Brabletz, T., Yu, M., Borenstein-Auerbach, N.,... Conacci-Sorrell, M. (2016). MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation. Proceedings of the National Academy of Sciences of the United States of America, 113(37), E5481-90. https://dx.doi.org/10.1073/pnas.1610994113
Luedeke, M., Rinckleb, A.E., Fitzgerald, L.M., Geybels, M.S., Schleutker, J., Eeles, R.A.,... Maier, C. (2016). Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Human Molecular Genetics, 25(24), 5490-5499. https://dx.doi.org/10.1093/hmg/ddw349
Lawrenson, K., Li, Q., Kar, S., Seo, J.-H., Tyrer, J., Spindler, T.J.,... Defazio, A. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications, 6, 8234. https://dx.doi.org/10.1038/ncomms9234
Lawrenson, K., Iversen, E.S., Tyrer, J., Weber, R.P., Concannon, P., Hazelett, D.J.,... Schildkraut, J.M. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis, 36(11), 1341-53. https://dx.doi.org/10.1093/carcin/bgv138

Last updated on 2016-10-05 at 08:26